169 related articles for article (PubMed ID: 25626406)
21. GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials.
Zhao Y; Polley EC; Li MC; Lih CJ; Palmisano A; Sims DJ; Rubinstein LV; Conley BA; Chen AP; Williams PM; Kummar S; Doroshow JH; Simon RM
Cancer Inform; 2015; 14(Suppl 2):45-55. PubMed ID: 25861217
[TBL] [Abstract][Full Text] [Related]
22. Clinical next generation sequencing of pediatric-type malignancies in adult patients identifies novel somatic aberrations.
Silva JG; Corrales-Medina FF; Maher OM; Tannir N; Huh WW; Rytting ME; Subbiah V
Oncoscience; 2015; 2(2):187-92. PubMed ID: 25859559
[TBL] [Abstract][Full Text] [Related]
23. On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients.
Schwaederle M; Daniels GA; Piccioni DE; Fanta PT; Schwab RB; Shimabukuro KA; Parker BA; Kurzrock R
Mol Cancer Ther; 2015 Jun; 14(6):1488-94. PubMed ID: 25852059
[TBL] [Abstract][Full Text] [Related]
24. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
25. What have we learned from exceptional tumour responses?: Review and perspectives.
Mehra N; Lorente D; de Bono JS
Curr Opin Oncol; 2015 May; 27(3):267-75. PubMed ID: 25811347
[TBL] [Abstract][Full Text] [Related]
26. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
[TBL] [Abstract][Full Text] [Related]
27. Application of molecular profiling in clinical trials for advanced metastatic cancers.
Kummar S; Williams PM; Lih CJ; Polley EC; Chen AP; Rubinstein LV; Zhao Y; Simon RM; Conley BA; Doroshow JH
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663694
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.
Normanno N; Rachiglio AM; Lambiase M; Martinelli E; Fenizia F; Esposito C; Roma C; Troiani T; Rizzi D; Tatangelo F; Botti G; Maiello E; Colucci G; Ciardiello F;
Ann Oncol; 2015 Aug; 26(8):1710-4. PubMed ID: 25851630
[TBL] [Abstract][Full Text] [Related]
29. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients.
Li Z; Guo X; Wu Y; Li S; Yan J; Peng L; Xiao Z; Wang S; Deng Z; Dai L; Yi W; Xia K; Tang L; Wang J
Breast Cancer Res Treat; 2015 Feb; 149(3):767-79. PubMed ID: 25636590
[TBL] [Abstract][Full Text] [Related]
30. TransVar: a multilevel variant annotator for precision genomics.
Zhou W; Chen T; Chong Z; Rohrdanz MA; Melott JM; Wakefield C; Zeng J; Weinstein JN; Meric-Bernstam F; Mills GB; Chen K
Nat Methods; 2015 Nov; 12(11):1002-3. PubMed ID: 26513549
[No Abstract] [Full Text] [Related]
31. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
Belardinilli F; Capalbo C; Buffone A; Petroni M; Colicchia V; Ferraro S; Zani M; Nicolussi A; D'Inzeo S; Coppa A; Screpanti I; Gulino A; Giannini G
Clin Biochem; 2015 Sep; 48(13-14):908-10. PubMed ID: 25872148
[TBL] [Abstract][Full Text] [Related]
32. Personalization of cancer treatment using predictive simulation.
Doudican NA; Kumar A; Singh NK; Nair PR; Lala DA; Basu K; Talawdekar AA; Sultana Z; Tiwari KK; Tyagi A; Abbasi T; Vali S; Vij R; Fiala M; King J; Perle M; Mazumder A
J Transl Med; 2015 Feb; 13():43. PubMed ID: 25638213
[TBL] [Abstract][Full Text] [Related]
33. Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis.
Campregher PV; Pereira WO; Lisboa B; Puga R; Helman R; Miyagi M; da Mata EH; Datoguia TS; Velloso ED; Bacal NS; Ross JS; Ali S; Miller V; Costa FF; Hamerschlak N; Santos FP
Mol Cancer; 2015 Nov; 14():197. PubMed ID: 26584717
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.
Wong V; Pavlick D; Brennan T; Yelensky R; Crawford J; Ross JS; Miller VA; Malicki D; Stephens PJ; Ali SM; Ahn H
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563356
[No Abstract] [Full Text] [Related]
35. Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms.
Burghel GJ; Hurst CD; Watson CM; Chambers PA; Dickinson H; Roberts P; Knowles MA
Biomed Res Int; 2015; 2015():478017. PubMed ID: 26351634
[TBL] [Abstract][Full Text] [Related]
36. Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
McAuliffe PF; Evans KW; Akcakanat A; Chen K; Zheng X; Zhao H; Eterovic AK; Sangai T; Holder AM; Sharma C; Chen H; Do KA; Tarco E; Gagea M; Naff KA; Sahin A; Multani AS; Black DM; Mittendorf EA; Bedrosian I; Mills GB; Gonzalez-Angulo AM; Meric-Bernstam F
PLoS One; 2015; 10(9):e0136851. PubMed ID: 26325287
[TBL] [Abstract][Full Text] [Related]
37. The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform.
Johnson A; Zeng J; Bailey AM; Holla V; Litzenburger B; Lara-Guerra H; Mills GB; Mendelsohn J; Shaw KR; Meric-Bernstam F
Drug Discov Today; 2015 Dec; 20(12):1433-8. PubMed ID: 26148707
[TBL] [Abstract][Full Text] [Related]
38. Gene-panel sequencing and the prediction of breast-cancer risk.
Easton DF; Pharoah PD; Antoniou AC; Tischkowitz M; Tavtigian SV; Nathanson KL; Devilee P; Meindl A; Couch FJ; Southey M; Goldgar DE; Evans DG; Chenevix-Trench G; Rahman N; Robson M; Domchek SM; Foulkes WD
N Engl J Med; 2015 Jun; 372(23):2243-57. PubMed ID: 26014596
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
